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Abstract: The Probability-Utility Model is dependent on the clinical practice guideline for its function. The Model func-
tions to provide decision analyses that demonstrate to clinicians and patients how personal preferences change the charac-
ter of best evidence. Initially, patients are provided a clinical practice guideline based on “average patient” best evidence. 
The Model works to demonstrate how decision, utility, and cost best evidence impact on decisions. It offers to patients an 
explanation of these impacts. Thus, patients may become more informed about the choices that go into making optimal 
clinical decisions for their own personal health care. The model also provides for visual images to be used in discussing 
their personal choices when considering different treatment options and clinical scenarios. The calculations accomplished 
through the Model provide trade-off analyses by which discussions may be facilitated between provider and patient in 
reaching informed consent and optimal clinical decisions in formulating treatment plans.  
INTRODUCTION 
Many advances have been made in reasoning best evi-
dence, especially in the form of judgments, inferences, and 
conclusions. While the Translational Evidence Mechanism 
provides the compact between researcher, clinicians, and 
patients by which this reasoning is developed, validated, 
disseminated, and refined, little progress has been made in 
producing technology to advance its practical use in display-
ing and utilizing this reasoning. Using dentistry as the disci-
pline, the purpose of this paper is to present a Probability-
Utility Model (Model),
1 firstly, for displaying and utilizing 
best evidence at chair side for shared decision-making. This 
shared decision-making occurs between dental provider and 
patient within the dental assessment, evaluation and treat-
ment planning appointment. Secondly, this model structures 
the inputs and outputs needed for storing and managing in-
formation within the central database of the Translational 
Evidence Mechanism.  
DECISION ALGORITHM 
Decision algorithms are decision trees, developed as ex-
pert systems. These systems structure: 
•  Clinical problems 
•  Analyze decisions and options, and 
•  Chose and implement clinical protocols or clini-
cal practice guidelines 
For dentistry, the decision tree that we propose for the 
central database is the Clinical Decision Tree of Oral Health 
(CDTOH) [1]. The CDTOH is a systematic understanding of  
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an entire decision process in rendering clinical decisions. It 
identifies the order of outcomes involved in diseases, treat-
ments and their protocols, and therapies in impacting posi-
tively on the oral health of patients. The outcome is the ter-
minal end of each of its branches. The best evidence that 
constitutes these terminal branches include decision, utility 
and cost data. These data variables vest the clinical practice 
guideline with best evidence for use in shared decision-
making.  Using the CDTOH, a structure of relationships is 
made in the central database. This structure consists of 9 
levels of evidence domains. These levels are developed to 
coincide with the flow of the decision process used in the 
CDTOH. Thus, each level of the hierarchy progressively 
adds information to the decision process. Thus, the clinical 
inquiry can follow the information trail until it reaches the 
actual data needed to respond to the initial inquiry. This is 
important to understand because the information collected 
along with the clinical inquiry: patient demographics, as-
sessments, and follow-ups, will impact on the data used to 
vest the CPG. For each level, information is managed to pri-
oritize the evidence that most impacts on the quantitative and 
qualitative nature of the response to query. For information 
technologists, this means structuring at each level requires 
normalization of the evidence across multiple tables, creating 
tables for decomposition (evidence stored secondary to the 
primary field key) and derivation (query responses that re-
quire calculation of the evidence). Information technologists 
perform these structuring tasks to improve and prevent de-
layed or time-consuming look-up of evidence in responding 
to queries. Programming language is used to provide the 
evidence to the generic template that displays the results of 
the query. 
NINE LEVELS OF EVIDENCE 
The nine levels of evidence include decision maker, 
physical and mental well-being, oral conditions, dental con-
ditions, oral functioning, prevention and maintenance, judg-
ment, values, and relationships domains. Each level has sub-
levels of variables that associate best evidence respective to 
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uses a dynamic process to prioritize each sublevel of evi-
dence such that best evidence is found to vest the CPG. This 
is a dynamic process because knowledge and relationships 
between outcomes change; in other words, the branches and 
their termini within an evidence domain develop new or 
eliminate previous known branches and termini. The new 
developments are in response to changes that are gathered 
from new clinical inquires, updates in decision analysis, and 
differences in the meaning of best evidence as analyzed from 
patient choices, lifestyles, and behaviors. Thus, these 
changes develop different relationships in response to new 
findings. 
In addition, the process must respond to queries that have 
single or multiple layers of comparison of evidence out-
comes. While complex in visage, the administration of these 
types of queries are well within the administration of a cen-
tral database. Using the decision maker level, as an example, 
four fields define decision makers: Dentist, Patient, Legal 
Surrogate, and Family members. Each decision maker im-
pacts on whether treatment is ordered or not ordered. Often, 
evidence at this level will determine the outcome of whether 
a treatment plan is offered, accepted, or not accepted. When 
treatment effectiveness and efficacy is uncertain, access and 
utilization of dental services by patients are uncertain. Often 
decision makers will rely on their personal utilities: previous 
dental experiences, health beliefs and behaviors, preferences, 
and health goals, in making decisions about access to dental 
care services. These lack the support from best evidence to 
clarify these utilities within the context of treatment out-
comes.  For example, evidence on functional status and ac-
cessing dental care services often affects how treatment op-
tions are communicated and decided upon by not only pa-
tients, but their dentists, legal surrogates, and family mem-
bers who may weight their personal utilities in adverse to 
potentially positive effective and efficacious outcomes. Evi-
dence on functional status provides estimates on life expec-
tancy. Life expectancy is predicted by demographic variables 
such as age, gender, and race. Utility measures include qual-
ity-adjusted life years (Miyamoto, Wakker, Bleichrodt, & 
Peters, 1998), or other utility assessments (Lin, Hwang, 
Chung, Huang, & Chen, 2006; Miyamoto, 2003; Miyamoto 
& Eraker, 1989). Cost is a variable considered later in the 
decision-making process when trade-offs between treatment 
options are discussed; unfortunately, cost may impact at this 
level when older adults, their dependents or caregivers, im-
pose preferences that rate higher estate interests over quality 
of life issues. Thus, the inclusion of multiple decision mak-
ers may make shared decision-making complex for access to 
dental care services, compliance in utilization, and improve-
ments in health outcomes from potential dental care services.  
INPUTS 
Research 
Research inputs vest the central database with data. 
These research inputs are utilized by the translational re-
searcher's role in providing best evidence for the central da-
tabase, evidence that will be used to respond to clinical que-
ries of dental providers for their patient consultations. Thus, 
there are two separate databases within the central database: 
An evidence-based database and research-vested database. 
The research database is important because the data inputted, 
then subsequently retrieved, is used to systematically derive 
best evidence for use in structuring outcome evidence for 
deriving clinical practice guidelines (CPGs). The evidence-
based database provides clinical queries with CPGs that con-
form to a specific organization of decision (outcome), utility 
(preferences and values), and cost best evidence. The Prob-
ability-Utility Model defines these inputs that are more di-
rected (requesting input of data in strict formats) than rea-
soned (summary statements) in providing research data for 
peer review by translational evidence researchers. The data 
inputted may be derived from research findings, unpublished 
manuscripts, and published articles. 
Clinical Practice 
Clinical inputs are specific inputs requested of clinicians. 
Clinician input provides clinical significance rankings of 
translational evidence researcher developed: 
•  CPGs 
•  CPGs returned as a product of shared decision-
making, or 
•  CPGs returned with follow-up assessments at 
patient periodic dental examinations.  
Clinicians are provided a CPG with best evidence spe-
cific to a stated clinical question. The clinician assesses best 
evidence for its applicability to private practice or patient 
care. Combined intuitive knowledge, clinical expertise and 
long-term monitoring of patient care qualifies the clinician to 
make these judgments. Once this data has been acquired and 
evidence systematically reviewed, best evidence is inputted 
into the central, evidence-based database. From there, a CPG 
is derived  and submitted for review of clinical significance 
by the clinician reviewer panel. A ranking is developed and 
inputted into the central, evidence-based database.  
Other clinical inputs from private practice include CPGs 
in which patients have rejected the utilities and cost esti-
mates based on "average patient" derived best evidence. In 
replacement of the "average patient" estimates, individual 
patients have stated estimates for their own. These estimates 
have been acquired from patient interaction and manipula-
tion of the CPG during shared decision-making. Once the 
optimal clinical decision is made these are inputted back to 
the translational evidence researcher for updating best evi-
dence from private practice. With a multitude of private 
practices, simulating research units, responding best evi-
dence may be updated using Bayesian statistics. In this man-
ner, the translational evidence researcher is alerted to derived 
CPG changes and acts accordingly to log, validate, and dis-
seminated in various ways these changes. This dissemination 
may act as an alert, or flag to the patient electronic chart 
from which the clinical question arose, and email alerts to 
dentists and researchers who have subscribed for this serv-
ice.  
Likewise, at each patient periodic dental examination and 
when appropriate, updates to decision and utility best evi-
dence are made. These outcomes of patient lifestyles and 
behaviors become new inputs to the database through the 
electronic chart and using the CPG. These inputs are based 
on observed differences from patient optimize decision and 
actual outcomes, behaviors, and compliance since the CPG Probability-Utility Model for Managing Evidence-based Central Database  The Open Dentistry Journal, 2010, Volume 4    63 
implementation. Within the database, these changes are ana-
lyzed to update the CPG. These updates also serve to inform 
researchers and clinicians how the original accepted opti-
mum clinical decision performed given the clinical scenario 
in which it was derived; in other words, the meaning in prac-
tice of the patient derived CPG.  
OUTPUTS 
Research 
Research outputs are research questions posed to the 
TEM in responding to a clinical inquiry. In this scenario, 
best evidence does not exist to answer the clinical question. 
Therefore, a research question is postulated to acquire data 
from the research community. Research outputs must be 
flexible enough to aid in research project development.  
Clinical Practice 
Clinical outputs are in the form of a CPG. The character 
of the CPG input template is provided in response to the 
clinical question, an example of which is stated:  In a popula-
tion of female subjects, 85 years of age and older, function-
ally independent, will dental implants, compared to remov-
able partial denture or no treatment, increase chewing func-
tion and chewing efficacy at a reasonable cost? Once the 
clinical question is submitted to the central, evidence-based 
database, a CPG is returned and attached to the patient's 
electronic chart.  
Probability-Utility Model 
The Probability-Utility Model provides derived evidence 
in the form of decision analyses that facilitate shared deci-
sion-making. Thus, the model not only defines inputs and 
outputs, but also the basis for why the central database and 
CPG product exists. It also provides: 
•  Best evidence modified by implementation in 
private practice 
•  Decision analyses for use in updating central da-
tabase evidence, and 
•  Analysis of best evidence performance, or its 
meaning in practice, to researchers and clini-
cians.  
Decision Analysis 
The decision analysis presents evidence in various ways 
for visualization and understanding of the CPG. Firstly, the 
CPG is offered with annotated descriptions of the evidence 
shown: Fig. (1) annotations describe the various chewing 
function effectiveness outcomes. Fig. (2) annotates the utili-
ties, and Fig. (3) the costs associated with each treatment 
option.  
The Probability-Utility Model, provides the trade-offs in 
considering which treatment option optimizes the clinical 
decision for the patient. This is done through roll-back 
calculations. Since the CPG is read from outcome to 
decision, so proceeds the calculations. To calculate the utility 
trade-offs between treatment options, the utility ranking is 
multiplied by the probability of the outcome. To calculate 
the cost trade-offs, the cost is multiplied by the probability of 
the outcome. Both provide dentist and patient with a 
description of the trade-off options for choosing the optimum 
clinical decision (Fig. 4).   
 
Fig. (1). Example CPG for decision data. 
DECISION
NODE
Dental 
Implants/
RPD
Date = 
Expiration = 
Functionally independent
Significance; S=, C=
Utility =
Utility Cost
High Risk
Dental 
Implants
High 
No treatment
Treat
Chewing 
Function
Chewing 
Function
Chewing 
Function
Treat
Treat
P=.8
P=.03
P=.97
P=.2
9 2750
5 1450
2 1000
CLINICAL PRACTICE GUIDELINE
The  probability of  a 
patient accepting 
implant treatment is 
.97; no treatment is .03
When comparing
treatments, the 
probability of  a patient 
accepting implant 
treatment  is .8;  RPD 
is .2
Example demonstrates best 
evidence for decision data using the 
CPG for high risk patient.64    The Open Dentistry Journal, 2010, Volume 4  Janet G. Bauer 
 
Fig. (2). Example CPG for utility data. 
 
Fig. (3). Example CPG for cost data. 
 
In this clinical scenario, comparisons of the stated treat-
ment options in an average women, 85 years and older, func-
tionally independent, and interested in state-of-the art treat-
ment, dental implants offer this patient better chewing effec-
tiveness far exceeding that provided by a RPD or No treat-
ment. With no treatment, there are still costs. If no treatment 
DECISION
NODE
Dental 
Implants/
RPD
Date = 
Expiration = 
Functionally independent
Significance; S=, C=
Utility =
Utility Cost
Equipoise Risk
Dental 
Implants
Equipoise
No treatment
Treat
Chewing 
Function
Chewing 
Function
Chewing 
Function
Treat
Treat
P=..69
P=.2
P=..8
P=..31
5 2750
5 1450
2 1000
CLINICAL PRACTICE GUIDELINE
The benefit to an 
average patient of 
implant treatment is 5; 
no treatment is  2
The  benefit to  an 
average patient of 
implant treatment is 5; 
RPD is 5 
Example demonstrates best 
evidence for utility data using the 
CPG for equipoise risk patient.
DECISION
NODE
Dental 
Implants/
RPD
Date = 
Expiration = 
Functionally independent
Significance; S=, C=
Utility =
Utility Cost
Low Risk
Dental 
Implants
Low
No treatment
Treat
Chewing 
Function
Chewing 
Function
Chewing 
Function
Treat
Treat
P=..17
P=.7
P=.3
P=.83
1 2750
6 1450
9 1000
CLINICAL PRACTICE GUIDELINE
The cost to the patient 
of implant treatment  is 
$2750; no treatment is 
$1000 
The  cost to  the patient 
of implant treatment  is 
$2750 ; RPD is  $1450
Example demonstrates cost data, or 
the hypothetical cost schedule class 
developed for the hypothetical 
Beverly Hills evidence-based dental 
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is selected, than the patient may experience costs in other or 
potential treatments due to not replacing teeth. These treat-
ments may include orthodontics, extraction of teeth, or 
periodontal conditions that may arise due to malocclusions. 
Using satisfaction rankings that an "average patient" with the 
same characteristics as this patient, dental implants far ex-
ceed that of wearing and eating with an RPD or no treatment. 
The cost of a dental implant compared to a RPD far exceeds 
that for a RPD or no treatment. With the options and their 
trade-offs, the dentist may discuss with the patient the option 
that best serves the patient’s needs, desires, and wants by 
comparing effectiveness, satisfaction levels, and cost. Thus, 
the optimal clinical decision is one that either accepts the 
option with the lowest costs or the largest expected value. If 
the patient, on the other hand, does not agree with the utility 
rankings, then the patient's rankings may replace those of the 
"average patient" with immediate revisions all trade-offs of 
each option having been recalculated. The interpretation of 
the analyses append the CPG so that viewing of CPG along 
with the interpretation may be seen simultaneously. Fig. (5) 
provides optimal clinical decisions based on risk level of the 
patient. 
Revision of Best Evidence 
Modification of, best evidence within the central, evi-
dence-based database may be performed simultaneously by 
updating the decision analysis. This revision of best evidence 
is done using Bayesian statistics. Updating best evidence 
 
Fig. (4). Decision-analysis for decision, utility, and cost data. 
 
Fig. (5). Interpretation of the decision-analysis using various risk levels. 
Probability-Utility Model
Interpretation of Analyses
DECISION ANALYSIS-HIGH RISK TAKER 
Decision Evidence Utility Evidence Cost Evidence
Decision:
*Rollback calculation for 
dental implant (.8x.97) 
=.77
*Rollback calculation for 
RPD (.2x.97) =.19
*Rollback calculation, 
No Tx = .03
Utility:
*Rollback calculation for 
dental implant 
(9 x.8) = 7.2
*Rollback calculation for 
RPD (5 x.2) =  1
*Roll back calculation, 
No Tx (2 x .03) = .06
Cost:
*Rollback calculation for 
dental implant ($2750
x.8) = $2200
*Rollback calculation for 
RPD ($1450 x .2) = $290
*Rollback calculation, 
No Tx ($1000 x .03) = 
$30
WHAT DOES THIS MEAN TO ME THE AVERAGE PATIENT?
Patient Risk 
Taker Category
Clinical Decision
High I get the greatest chewing  function (effectiveness) that meets my highest 
expectations (efficiency) with implant treatment over all other choices (trade-
offs). While this treatment costs the most, its effectiveness and efficiency to 
my oral health is worth it. 
Equipoise I get the best choice with RPD treatment. It provides me a reasonable increase 
in chewing function and is just as efficacious a treatment as that for implant. 
The cost is certainly much better and the best trade-off to no treatment. I can 
be satisfied with my choice because no treatment is the least acceptable and 
cost about half as much as RPD treatment. In addition, RPD treatment is 
certainly cheaper than implant treatment while giving me the same 
satisfaction.  
Low I get the best of chewing function and satisfaction with RPD treatment. While 
it still costs me more, it is not enough for me to accept no treatment. If I loose 
my job, I know that no treatment is going to cost me later on and I will not get 
as much chewing function or satisfaction as I would if I accepted RPD 
treatment. While the dentist’s profit margin and expectation of chewing 
effectiveness is higher with implant treatment, RPD treatment does beat no 
treatment in a trade-off with no treatment. 
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determines if the prior probabilities of treatment options are 
mitigated by probabilities or revised probabilities of other 
events. In other words, the prior probabilities of treatment 
outcomes are conditional on the probabilities of the evidence 
witnessed in private practice and updated through the elec-
tronic chart using the CPG. This analysis is performed using 
Baye's theorem. Bayes’s theorem is a formula for calculating 
the conditional probability of one event from the conditional 
probability of the other event.  
Aside from updating probabilities, patient decision-
making and new knowledge changes the understanding of 
evidence. With sensitivity analysis, the translational re-
searcher evaluates for clinicians and researchers ways deci-
sions change as a function of changing probabilities, utilities, 
and costs. Sensitivity analysis also predicts the type of evi-
dence that was most relevant to patients when considering 
trade-offs between two or more presenting treatment options. 
This information serves to enlighten understanding regarding 
patient preferences and values, behaviors, and compliance.  
SUMMARY 
The Probability-Utility Model is a way of understanding 
how optimize clinical decisions are derived through the use 
of a clinical practice guideline. The Model demonstrates how 
decision analysis is accomplished in explaining to clinicians 
and patients the use of best evidence in decision-making. 
Decision-making is comprised of decision, utility and cost 
data. These data variables are needed to make optimum deci-
sions that take into account patient needs, desires and wants. 
The model sets forth the structure of these components 
within the clinical practice guideline. The Model, then, oper-
ates on each component to demonstrate what best evidence 
means to a decision. Then progresses to demonstrate the val-
ues a patient holds in assessing different treatment outcomes 
and cost/benefit trade-offs. By changing the values provided 
in an initial rendering of data, the patient may express their 
choices and visualize how personal preferences change best 
evidence, conform best evidence to their self-interests, and 
provide data to be used in updating current best evidence.  
REFERENCES 
[1]  Bauer JG, Spackman S, Edwards W. The clinical decision tree of 
oral health in geriatrics. In: Weis JW, Weiss DJ, Eds. a science of 
decision making, the legacy of Ward Edwards, Oxford University 
Press 2009; 34: 461-75. 
 
 
 
Received: September 16, 2009  Revised: October 05, 2009  Accepted: October 05, 2009 
 
© Janet G. Bauer; Licensee Bentham Open. 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the 
work is properly cited. 
 
 
 